Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations
AbstractBackground. Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.Methods. Using its networking and shar
AbstractBackground. Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.Methods. Using its networking and shar
Learn more about a 56-year-old woman diagnosed with well-differentiated papillary mesothelioma, and how she was diagnosed and properly treated.
Health Affairs Scholar is a fully open access, peer-reviewed journal of emerging and global health policy. Published under the aegis of Health Affairs and Proje
AbstractBackground and aims. Data describing the long-term efficacy, safety, and tolerability of inclisiran are limited. This was explored in ORION-8, an o
Valerae Lewis, M.D., is a leader in the field of orthopedic oncology and chairs MD Anderson’s Orthopaedic Oncology department. Here, she shares what led her…
Abstract. Low-dose colchicine (0.5 mg daily) is now FDA-approved for secondary prevention in patients with coronary disease and will be increasingly prescr
Enhancing DEI in Clinical Research: Strategies Used by Clinical Investigators
NICE recommends Oncotype DX to guide chemotherapy decisions in early-stage, HR-positive, HER2-negative breast cancer involving up to 3 positive nodes.
Genome-driven precision oncology has revolutionized cancer treatment and opened doors to tissue-agnostic precision medicine. Kummar et al.’s study confirms the effectiveness of neurotrophic receptor …
AbstractObjective. Thresholds for overweight and obesity are currently defined by body mass index (BMI), a poor surrogate marker of actual adiposity (perce
Here, we summarize results from a phase II trial assessing the safety and efficacy of acalabrutinib in combination with lenalidomide and rituximab in patients with…